Back to RecallTracker
Health Canada Health products

APO-AMITRIPTYLINE Tablets: NNORT impurity

Issued August 14, 2023
Issue
Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT).
Hazard description
Contamination
What to do
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Product
Product name
APO-AMITRIPTYLINE Tablets
Reference
ID
RA-74114